Financial results - SRS NEUROMED S.R.L.

Financial Summary - Srs Neuromed S.r.l.
Unique identification code: 41803732
Registration number: J2019001748040
Nace: 8622
Sales - Ron
33.801
Net Profit - Ron
5.360
Employees
Open Account
Company Srs Neuromed S.r.l. with Fiscal Code 41803732 recorded a turnover of 2024 of 33.801, with a net profit of 5.360 and having an average number of employees of - . The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Srs Neuromed S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 164 5.339 10.927 13.545 25.782 33.801
Total Income - EUR - - - - 164 5.339 10.927 13.545 25.782 33.801
Total Expenses - EUR - - - - 28 1.213 4.101 6.266 12.658 25.509
Gross Profit/Loss - EUR - - - - 136 4.126 6.826 7.279 13.124 8.291
Net Profit/Loss - EUR - - - - 131 3.972 6.531 6.964 10.434 5.360
Employees - - - - 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 31.8%, from 25.782 euro in the year 2023, to 33.801 euro in 2024. The Net Profit decreased by -5.016 euro, from 10.434 euro in 2023, to 5.360 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Srs Neuromed S.r.l.

Rating financiar

Financial Rating -
SRS NEUROMED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Srs Neuromed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Srs Neuromed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Srs Neuromed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Srs Neuromed S.r.l. - CUI 41803732

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 281 898 1.277 1.071 50.412 37.602
Current Assets - - - - 203 3.623 5.409 7.182 13.142 7.758
Inventories - - - - 0 310 1.074 1.493 1.871 2.042
Receivables - - - - 0 944 2.280 5.415 10.095 402
Cash - - - - 203 2.369 2.054 274 1.175 5.315
Shareholders Funds - - - - 174 4.142 6.571 7.005 10.474 5.820
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 310 378 206 1.277 53.187 39.540
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 7.758 euro in 2024 which includes Inventories of 2.042 euro, Receivables of 402 euro and cash availability of 5.315 euro.
The company's Equity was valued at 5.820 euro, while total Liabilities amounted to 39.540 euro. Equity decreased by -4.596 euro, from 10.474 euro in 2023, to 5.820 in 2024.

Risk Reports Prices

Reviews - Srs Neuromed S.r.l.

Comments - Srs Neuromed S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.